#term ID	term description	observed gene count	background gene count	strength	signal	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
WP5095	Overview of proinflammatory and profibrotic mediators	8	126	1.1	0.88	0.00031	9606.ENSP00000263851,9606.ENSP00000296026,9606.ENSP00000296027,9606.ENSP00000327513,9606.ENSP00000367832,9606.ENSP00000378517,9606.ENSP00000385675,9606.ENSP00000474412	IL7,CXCL3,CXCL5,CSF1,CCL7,SPP1,IL6,CCL5
WP3624	Lung fibrosis	5	63	1.19	0.58	0.0075	9606.ENSP00000218388,9606.ENSP00000222390,9606.ENSP00000378517,9606.ENSP00000385675,9606.ENSP00000474412	TIMP1,HGF,SPP1,IL6,CCL5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	5	66	1.17	0.58	0.0075	9606.ENSP00000296026,9606.ENSP00000296027,9606.ENSP00000312002,9606.ENSP00000385675,9606.ENSP00000474412	CXCL3,CXCL5,HAVCR2,IL6,CCL5
WP5115	Network map of SARS-CoV-2 signaling pathway	8	218	0.86	0.53	0.0075	9606.ENSP00000263851,9606.ENSP00000296026,9606.ENSP00000296027,9606.ENSP00000385519,9606.ENSP00000385675,9606.ENSP00000391592,9606.ENSP00000415769,9606.ENSP00000474412	IL7,CXCL3,CXCL5,CD14,IL6,PTPN6,ITIH3,CCL5
WP3888	VEGFA-VEGFR2 signaling	10	428	0.66	0.46	0.0099	9606.ENSP00000220764,9606.ENSP00000248553,9606.ENSP00000285735,9606.ENSP00000299427,9606.ENSP00000339328,9606.ENSP00000356436,9606.ENSP00000362680,9606.ENSP00000369081,9606.ENSP00000391592,9606.ENSP00000416255	DECR1,HSPB1,RHOC,TPP1,PLAUR,PLA2G4A,SRC,TXNDC5,PTPN6,EIF4G1
WP4172	PI3K-Akt signaling pathway	9	336	0.72	0.48	0.0099	9606.ENSP00000222390,9606.ENSP00000261405,9606.ENSP00000263851,9606.ENSP00000321326,9606.ENSP00000327513,9606.ENSP00000355751,9606.ENSP00000378517,9606.ENSP00000384849,9606.ENSP00000385675	HGF,VWF,IL7,F2R,CSF1,THBS2,SPP1,CDKN1A,IL6
WP4136	Fibrin complement receptor 3 signaling pathway	4	43	1.26	0.56	0.0103	9606.ENSP00000296026,9606.ENSP00000362680,9606.ENSP00000385519,9606.ENSP00000385675	CXCL3,SRC,CD14,IL6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	4	47	1.22	0.53	0.0125	9606.ENSP00000362680,9606.ENSP00000385675,9606.ENSP00000428924,9606.ENSP00000462468	SRC,IL6,LYN,YES1
WP2848	Pluripotent stem cell differentiation pathway	4	47	1.22	0.53	0.0125	9606.ENSP00000222390,9606.ENSP00000327513,9606.ENSP00000381775,9606.ENSP00000385675	HGF,CSF1,TNFSF11,IL6
WP286	IL-3 signaling pathway	4	49	1.21	0.53	0.0125	9606.ENSP00000346300,9606.ENSP00000362680,9606.ENSP00000391592,9606.ENSP00000428924	CRKL,SRC,PTPN6,LYN
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3	19	1.49	0.55	0.0127	9606.ENSP00000248553,9606.ENSP00000378517,9606.ENSP00000385675	HSPB1,SPP1,IL6
WP2507	Nanomaterial induced apoptosis	3	20	1.47	0.54	0.0134	9606.ENSP00000258080,9606.ENSP00000287295,9606.ENSP00000499058	HTRA2,AIFM1,DIABLO
WP3929	Chemokine signaling pathway	6	165	0.86	0.47	0.0139	9606.ENSP00000296026,9606.ENSP00000296027,9606.ENSP00000346300,9606.ENSP00000367832,9606.ENSP00000428924,9606.ENSP00000474412	CXCL3,CXCL5,CRKL,CCL7,LYN,CCL5
WP304	Kit receptor signaling pathway	4	59	1.13	0.5	0.0152	9606.ENSP00000346300,9606.ENSP00000362680,9606.ENSP00000391592,9606.ENSP00000428924	CRKL,SRC,PTPN6,LYN
WP4205	MET in type 1 papillary renal cell carcinoma	4	58	1.13	0.5	0.0152	9606.ENSP00000222390,9606.ENSP00000346300,9606.ENSP00000362680,9606.ENSP00000384849	HGF,CRKL,SRC,CDKN1A
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4	62	1.1	0.48	0.0170	9606.ENSP00000339186,9606.ENSP00000378845,9606.ENSP00000391592,9606.ENSP00000442600	GRAP2,LAT,PTPN6,DAG1
WP530	Cytokines and inflammatory response	3	26	1.36	0.49	0.0191	9606.ENSP00000263851,9606.ENSP00000327513,9606.ENSP00000385675	IL7,CSF1,IL6
WP306	Focal adhesion	6	195	0.78	0.41	0.0228	9606.ENSP00000222390,9606.ENSP00000261405,9606.ENSP00000346300,9606.ENSP00000355751,9606.ENSP00000362680,9606.ENSP00000378517	HGF,VWF,CRKL,THBS2,SRC,SPP1
WP4754	IL-18 signaling pathway	7	271	0.71	0.4	0.0228	9606.ENSP00000218388,9606.ENSP00000248553,9606.ENSP00000296026,9606.ENSP00000378517,9606.ENSP00000381775,9606.ENSP00000385675,9606.ENSP00000474412	TIMP1,HSPB1,CXCL3,SPP1,TNFSF11,IL6,CCL5
WP313	Hepatocyte growth factor receptor signaling	3	34	1.24	0.42	0.0335	9606.ENSP00000222390,9606.ENSP00000346300,9606.ENSP00000362680	HGF,CRKL,SRC
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	7	301	0.66	0.36	0.0357	9606.ENSP00000222390,9606.ENSP00000261405,9606.ENSP00000321326,9606.ENSP00000327513,9606.ENSP00000355751,9606.ENSP00000378517,9606.ENSP00000384849	HGF,VWF,F2R,CSF1,THBS2,SPP1,CDKN1A
WP4298	Acute viral myocarditis	4	85	0.97	0.38	0.0382	9606.ENSP00000362680,9606.ENSP00000385675,9606.ENSP00000416255,9606.ENSP00000442600	SRC,IL6,EIF4G1,DAG1
WP5285	Immune infiltration in pancreatic cancer	3	38	1.19	0.4	0.0394	9606.ENSP00000296027,9606.ENSP00000385675,9606.ENSP00000474412	CXCL5,IL6,CCL5
WP1772	Apoptosis modulation and signaling	4	89	0.95	0.37	0.0413	9606.ENSP00000258080,9606.ENSP00000287295,9606.ENSP00000365435,9606.ENSP00000499058	HTRA2,AIFM1,TNFRSF1B,DIABLO
WP3937	Microglia pathogen phagocytosis pathway	3	40	1.17	0.39	0.0413	9606.ENSP00000378845,9606.ENSP00000391592,9606.ENSP00000428924	LAT,PTPN6,LYN
WP673	ErbB signaling pathway	4	89	0.95	0.37	0.0413	9606.ENSP00000233154,9606.ENSP00000346300,9606.ENSP00000362680,9606.ENSP00000384849	NCK2,CRKL,SRC,CDKN1A
WP69	T-cell receptor signaling pathway	4	90	0.94	0.37	0.0413	9606.ENSP00000339186,9606.ENSP00000346300,9606.ENSP00000378845,9606.ENSP00000385675	GRAP2,CRKL,LAT,IL6
WP23	B cell receptor signaling pathway	4	97	0.91	0.36	0.0480	9606.ENSP00000346300,9606.ENSP00000391592,9606.ENSP00000423602,9606.ENSP00000428924	CRKL,PTPN6,DAPP1,LYN
WP5087	Malignant pleural mesothelioma	8	434	0.56	0.32	0.0484	9606.ENSP00000222390,9606.ENSP00000296027,9606.ENSP00000327513,9606.ENSP00000362680,9606.ENSP00000384849,9606.ENSP00000385675,9606.ENSP00000416255,9606.ENSP00000474412	HGF,CXCL5,CSF1,SRC,CDKN1A,IL6,EIF4G1,CCL5
